Avid Bioservices (CDMO) Tops Q1 EPS by 2c, Revenues Beat; Offers FY20 Revenue Mid-Point Guidance Above Consensus

Go back to Avid Bioservices (CDMO) Tops Q1 EPS by 2c, Revenues Beat; Offers FY20 Revenue Mid-Point Guidance Above Consensus
(NASDAQ: CDMO) Delayed: 12.49 --0 (-0%)
Previous Close $12.49    52 Week High $ 
Open $12.49    52 Week Low $ 
Day High $12.49    P/E N/A 
Day Low $12.49    EPS $ 
Volume 4,234,715